96450-2
LaboratoryHepatotocellular carcinoma risk [Score] GALAD
Definition
The GALAD score provides the probability of a patient having hepatocellular carcinoma (HCC). It is calculated based on gender, age, alpha-fetoprotein (AFP)-L3, AFP, and des-gamma-carboxy prothrombin [DCP], and higher GALAD model scores correlate with increased risk of HCC. The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.
LOINC 6-Axis Classification
Component
Hepatocellular carcinoma risk
Property
Score
Time Aspect
Pt
System
^Patient
Scale Type
Qn
Method Type
GALAD
Details
Class
CHEM
Order/Observation
Observation
Short Name
GALAD Score
Display Name
Hepatotocellular carcinoma risk [Score] GALAD
Related Names
Frequently Asked Questions
What is LOINC code 96450-2?
LOINC code 96450-2 identifies "Hepatotocellular carcinoma risk [Score] GALAD". The GALAD score provides the probability of a patient having hepatocellular carcinoma (HCC). It is calculated based on gender, age, alpha-fetoprotein (AFP)-L3, AFP, and des-gamma-carboxy prothrombin [DCP], and higher GALAD model scores correlate with increased risk of HCC. The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.
What does 96450-2 measure?
This code measures Hepatocellular carcinoma risk in ^Patient. It belongs to the CHEM class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.